NeuroPace Inc - Common Stock, $0.01 par value (NPCE)

CUSIP: 641288105

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
-1,409,602
Put/Call ratio
2.2%
SEC-reported price per share
$11.14
Number of holders
98
Value change
-$19,749,912
Number of buys
67
Open additional details 1 more signal available
Number of sells
35
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
34,087,924

Security key

641288105

Report period

Q2 2025

Institutions

98

Top holders

10

Ownership snapshot

Top reported holders of NPCE - NeuroPace Inc - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Polar Capital Holdings Plc
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F 13D/G 3/4/5 Lead comparable stake: 9.1% 13D/G row: Polar Capital Holdings Plc Showing 1-6 of 15 holder rows.

Quick read

Polar Capital Holdings Plc leads the comparable SEC ownership view at 9.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Polar Capital Holdings Plc's linked filing trail.
Comparable ownership Top 5
Polar Capital Holdings Plc 9.1%
MORGAN STANLEY 8.3%
Soleus Capital Master Fund, L.P. 7%
Kent Lake PR LLC 4.9%
ORBIMED ADVISORS LLC 9.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Polar Capital Holdings Plc
13F 13D/G
Company
9.1%
from 13D/G
$36,525,917
2,972,003 shares
31 Mar 2025
MORGAN STANLEY
13F 13D/G
Company
8.3%
from 13D/G
$31,101,321
2,530,620 shares
31 Mar 2025
Soleus Capital Master Fund, L.P.
13D/G
Soleus Capital Management, L.P.
7%
$23,545,122
2,303,828 shares
$0 30 Jun 2025
Kent Lake PR LLC
13D/G 13F
Company
4.9%
$17,227,289
1,482,555 shares
+$116,944 31 Dec 2024
ORBIMED ADVISORS LLC
3/4/5 13F
10%+ Owner · Company
9.5%
$51,616,892
3,238,199 shares
14 May 2025
Soleus Capital Management, L.P.
13F
Company
13F
7.7%
$32,054,385
2,608,168 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
98
Shares
22,505,448
Rows available
98
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
89
Q2 2025 holders
98
Holder diff
9
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .